Actively Recruiting

Age: 10Years - 65Years
FEMALE
Healthy Volunteers
ID06067529

A Multicenter Observational Study on the Development and Health Effects of Premature Ovarian Insufficiency

Led by Women's Hospital School Of Medicine Zhejiang University · Updated on 2026-05-28

1080

Participants Needed

2

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Premature ovarian insufficiency (POI) occurs when ovarian function declines in women before age 40, significantly affecting health and quality of life. This research aims to better understand the causes, progression, and health impacts of POI, as well as evaluate hormone replacement therapy (HRT) options. The study will create a hospital-based, multi-center case-control and prospective cohort to gather comprehensive data on POI's natural course and effects. The study includes several groups: women diagnosed with POI, control women with regular menstrual cycles, those scheduled for ovarian surgery, and those undergoing oophorectomy. Participants provide biological samples, lifestyle and health information, and undergo long-term follow-up assessments. Data collection spans multiple health factors including reproductive hormones, bone density, psychological well-being, and metabolic markers. Participants will be monitored at regular intervals up to 36 months with tests such as bone density scans, hormone level checks, blood glucose and insulin measurements, and psychological assessments for anxiety and depression. The study also tracks symptoms related to low estrogen and sexual health. Safety and health outcomes are observed through blood counts, liver and kidney function tests, and ultrasound exams. This comprehensive approach aims to deepen understanding and support improved care for women with POI.

CONDITIONS

Brief Title

A Multicenter Observational Study on the Development and Health Effects of Premature Ovarian Insufficiency

Who Can Participate

Age: 10Years - 65Years
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Women diagnosed with premature ovarian insufficiency before age 40, meeting specific diagnostic criteria
  • Women aged 18 to 50 with regular menstrual cycles (21-35 days) for the past 12 months for control group
  • Women aged 18 to 60 scheduled for ovarian surgery for gynecological disease
  • Women aged 45 to 65 scheduled for oophorectomy due to gynecological diseases and menopausal status
  • Willingness to participate, provide biological samples, and complete long-term follow-up assessments or provide informed consent
Not Eligible

You will not qualify if you...

  • Current pregnancy or breastfeeding
  • Severe systemic diseases such as active malignancy unrelated to POI, severe heart or kidney failure, cognitive impairment
  • History of reproductive disorders like PCOS, endometriosis, or other reproductive pathologies
  • Prior ovarian surgery, chemotherapy, or radiotherapy for control group
  • History of endocrine, autoimmune, cardiovascular, liver, kidney, hematological diseases, or malignancy
  • Genetic or chromosomal abnormalities such as Turner syndrome or other genetic diseases
  • Use of hormonal drugs or contraceptives within the last 6 months
  • Women seeking assisted reproductive technology

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Long-term Monitoring

Duration - Up to 36 months

Participants provide biological samples and complete assessments to monitor health effects and development of premature ovarian insufficiency over time.

Visits at baseline, 6 months, 12 months, 24 months, and 36 months

Trial Site Locations

Total: 2 locations

1

Women's Hospital School of Medicine Zhejiang University

Hangzhou, Zhejiang, China, 310000

Actively Recruiting

2

Women's Hospital School of Medicine Zhejiang University

Hangzhou, Zhejiang, China, 310000

Not Yet Recruiting

Loading map...

Research Team

J

Jianhong Zhou, Doctor of Medicine(M.D.)

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

4

Similar Trials

Application of Autologous Adipose Stromal Vascular Fraction ...

Premature Ovarian Insufficiency

Actively Recruiting

1 location

Application of Platelet-rich Plasma (PRP) in Reproductive Me...

Premature Ovarian Insufficiency

Actively Recruiting

1 location

Clinical Application of Serum Anti-Müllerian Hormone (AMH) M...

Anti-Müllerian Hormone

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here